Status:

COMPLETED

Interleukine 6 as a Predictor of Outcome in Mechanically Ventilated Patients With Covid 19

Lead Sponsor:

Sohag University

Conditions:

Mechanical Ventilation Duration

Eligibility:

All Genders

20+ years

Brief Summary

Serum IL-6 levels will be determined by enzyme-linked immunosorbent assay according to the manufacturer's instructions and the normal range is \<10 pg/mL , Patients' medical records will be carefully ...

Eligibility Criteria

Inclusion

  • •Age: more than 20 years.
  • Gender: both males and females will be included.
  • Mechanically Ventilated patients.
  • COVID 19 confirmed diagnosis

Exclusion

  • •Immunocompromised patients.
  • Oxygen saturation more than 95% without ventilation.
  • Malignancy.
  • Patients refuse to be enrolled in the study.

Key Trial Info

Start Date :

June 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2022

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT05274503

Start Date

June 1 2021

End Date

January 1 2022

Last Update

March 10 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sohag University, Faculty of Medicine

Sohag, Egypt

Interleukine 6 as a Predictor of Outcome in Mechanically Ventilated Patients With Covid 19 | DecenTrialz